Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1996
Full metadata record
DC FieldValueLanguage
dc.contributorMangira, D.en_US
dc.contributorRaftopoulos, S.en_US
dc.contributorHartley, I.en_US
dc.contributorMack, A.en_US
dc.contributorGazelakis, K.en_US
dc.contributorNalankilli, K.en_US
dc.contributorElliott, Timothy R.en_US
dc.contributorMoss, A.en_US
dc.date.accessioned2022-11-14T23:07:30Z-
dc.date.available2022-11-14T23:07:30Z-
dc.date.issued2022-
dc.identifier.govdoc01950en_US
dc.identifier.urihttp://hdl.handle.net/11054/1996-
dc.description.abstractAims: CSP is the standard of care for resecting small (<10mm) colonic polyps. However, limited data exists for its efficacy for medium-sized (10-19mm) sessile polyps. This study evaluated the efficacy and safety of CSP/C-EMR for medium-sized sessile colonic polyps. Methods: An Australian prospective multicentre study was conducted between May-2018 and June-2021, including all consecutive cases of CSP/C-EMR for 10-19mm sessile colonic polyps. Once resection was deemed complete, the margins of resection sites were biopsied circumferentially and centrally. Primary outcome: presence of residual polyp in these biopsy specimens. Secondary outcomes: recurrence rate at first surveillance colonoscopy and rates of adverse events. Results: CSP/C-EMR was performed for 350 polyps in 295 patients. Median polyp size: 15mm. Submucosal injection to lift polyps was used in 87.1% (n=305) of polyps. Histology: 68.5% adenomas, 26.2% SSA/P without dysplasia, 3.8% SSA/P with dysplasia and 1.4% hyperplastic polyps. Primary outcome: Margin and central biopsies were positive in 1.7%(n=6) and 0.3%(n=1) of polyps respectively. Secondary outcomes: Polyp recurrence was present in 1.7%(n=4) of cases at first surveillance colonoscopy that had been completed for 64.2%(n=225) of polyps at a median interval of 9.7 months. Adverse events occurred in 3.4%(n=10) of patients: 1 had intraprocedural bleeding (clipped), 3 had self-limiting post-polypectomy bleeding, 4 had post-polypectomy pain and 2 had post-polypectomy syndrome. There were no perforations. Conclusions: CSP/C-EMR for 10-19mm sessile colonic polyps is highly effective and safe. Rates of incomplete resection and recurrence at surveillance were low, with few adverse events.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-11-10T00:14:30Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-11-14T23:07:30Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2022-11-14T23:07:30Z (GMT). No. of bitstreams: 0 Previous issue date: 2022en
dc.titleCold snare polypectomy (CSP)/Cold EMR (C-EMR) for medium-sized (10-19mm) sessile colonic polyps: A prospective multicentre study.en_US
dc.typeConferenceen_US
dc.type.specifiedPaperen_US
dc.bibliographicCitation.conferencedateApril 28-30en_US
dc.bibliographicCitation.conferencenameESGE Days 2022en_US
dc.bibliographicCitation.conferenceplacePragueen_US
dc.subject.healththesaurusCOLONIC POLYPSen_US
dc.subject.healththesaurusCOLD SNARE POLYPECTOMYen_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.